TAK
Takeda Pharmaceutical·NYSE
--
--(--)
--
--(--)
TAK fundamentals
Takeda Pharmaceutical (TAK) released its earnings on Jan 29, 2026: revenue was 7.76B (YoY +5.08%), beat estimates; EPS was 0.2142 (YoY +338.04%), beat estimates.
Revenue / YoY
7.76B
+5.08%
EPS / YoY
0.2142
+338.04%
Report date
Jan 29, 2026
TAK Earnings Call Summary for Q3,2026
- Pipeline Success: Three Phase III assets (oveporexton, rusfertide, zasocitinib) exceed expectations, positioning Takeda for 2027 launches to offset ENTYVIO biosimilar risk.
- Financial Resilience: Q3 revenue (-3.3% YoY) and core OP (-3.4% YoY) reflect VYVANSE generic erosion, but 6.7% growth in launch products (ENTYVIO Pen, TAKHZYRO) signals recovery.
- Strategic Adjustments: Organizational restructuring and AI adoption aim to accelerate launches, while progressive dividend policy supports shareholder returns.
- Key Risks: ENTYVIO IRA price cuts (2028) and TAKHZYRO competitor pressure highlight need for disciplined cost management and pipeline diversification.
EPS
Revenue
Revenue & Expenses
TAK has released its 2026 Q3 earnings report, with revenue of 7.60B, reflecting a YoY change of 4.54%, and net profit of 661.56M, showing a YoY change of 336.80%. The Sankey diagram below clearly presents TAK's revenue sources and cost distribution.
Key Indicators
Takeda Pharmaceutical (TAK) key financial stats and ratios, covering profitability, financial health, and leverage.
Takeda Pharmaceutical (TAK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Takeda Pharmaceutical (TAK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Takeda Pharmaceutical (TAK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Takeda Pharmaceutical (TAK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Takeda Pharmaceutical (TAK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Takeda Pharmaceutical's management provide for the next earnings period?Did Takeda Pharmaceutical beat or miss consensus estimates last quarter?What does Takeda Pharmaceutical do and what are its main business segments?What is Takeda Pharmaceutical's gross profit margin?What were the key takeaways from Takeda Pharmaceutical's earnings call?What is the revenue and EPS growth rate for Takeda Pharmaceutical year over year?What factors drove the changes in Takeda Pharmaceutical's revenue and profit?What is the market's earnings forecast for Takeda Pharmaceutical next quarter?
